Preparation of liposomal doxorubicin-graphene nanosheet and evaluation of its in vitro anti-cancer effects.
Antineoplastic Agents
/ pharmacology
Cell Survival
/ drug effects
Doxorubicin
/ analogs & derivatives
Drug Carriers
/ chemistry
Drug Liberation
Ethanolamines
/ chemistry
Graphite
/ chemistry
Humans
Liposomes
/ chemistry
MCF-7 Cells
Nanostructures
/ chemistry
Particle Size
Phosphorylcholine
/ chemistry
Polyethylene Glycols
/ pharmacology
Nanoliposome
cancer therapy
doxorubicin
graphene nanosheet
multifunctional system
Journal
Journal of liposome research
ISSN: 1532-2394
Titre abrégé: J Liposome Res
Pays: England
ID NLM: 9001952
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
pubmed:
22
9
2018
medline:
16
8
2019
entrez:
22
9
2018
Statut:
ppublish
Résumé
In recent years there has been much interest in development of multifunctional drug delivery systems. In this work, liposomes that contain doxorubicin (Dox), a potent anticancer drug, and graphene nanosheets (GNS) were prepared. The GNSs have excellent optical properties, such as photoluminescence which enables tracking of the liposomes, high absorption in ultra violet region of electromagnetic spectrum which can be exploited in photodynamic and photothermal therapy, and low toxicity to mammalian cells. Nanoliposomes were prepared using the thin film hydration method. Dox and GNSs were loaded to the liposomes during the hydration of the lipid film. Liposomes were characterized and the profile of in vitro drug release, cellular uptake, and cytotoxicity of the prepared liposomes on MCF-7 cells were determined. Despite the earlier reports, the liposomes have kept their spherical structures in the presence of GNSs. The cytotoxicity of liposomal Dox and GNSs were shown to be higher than the free forms of them. Novel nanoliposomes that contain GNSs have provided a multi-functional system with the potential of tracking, photodynamic and photothermal therapy. Further improvements of this versatile nanosystem would be promising for treatment of cancer.
Identifiants
pubmed: 30235963
doi: 10.1080/08982104.2018.1524481
doi:
Substances chimiques
Antineoplastic Agents
0
Drug Carriers
0
Ethanolamines
0
Liposomes
0
liposomal doxorubicin
0
Phosphorylcholine
107-73-3
Polyethylene Glycols
3WJQ0SDW1A
Graphite
7782-42-5
phosphorylethanolamine
78A2BX7AEU
Doxorubicin
80168379AG
Types de publication
Journal Article
Langues
eng